Skip to content

Central Sensitization in Chronic Whiplash Patients

Central Sensitization in Chronic Whiplash Patients: Metabolite Concentrations in the Anterior Cingulate Cortex and Periacueductal Gray Matter

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03005691
Enrollment
30
Registered
2016-12-29
Start date
2017-01-31
Completion date
2017-05-31
Last updated
2016-12-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Pain

Keywords

metabolite, central sensitization, whiplash

Brief summary

The purpose of this study is to determine whether the metabolite concentrations within the anterior cingulate cortex and periaqueductal gray matter predict the intensity and interference of neuropathic pain after the development of chronic whiplash syndrome.

Detailed description

Persistent chronic pain is a common symptom of whiplash leading to reduced quality of life. Little information is available regarding changes in brain processing areas and change in central sensitization to noxious input during the chronic phase of whiplash. Metabolite concentrations in the anterior cingulate cortex and periaqueductal gray matter may be predictors of neuropathic pain and these changes may explain the development of central sensitization in people with chronic whiplash. Until now, there is not any study that show this approach.

Interventions

RADIATIONSpectroscopy

Spectroscopy is a noninvasive method to assess brain chemistry. The signal of the hydrogen atom attached to a certain molecule or metabolite has a particular frequency associated with a given metabolite. The utility of Spectroscopy is based on the fact thet the nuclei of atoms have magnetic properties that can be used to obtain chemical information regarding both the type of molecule and it is concentration. The subjects will be scanned on a 3-T Siemens system and an 12-channel phased-array coil will be used to provide an optimum signal-to-noise ratio for spectroscopy data.

OTHERQuestionnaires

Questionnaires are important to assess the chronic pain and their impact in the quality of life. For this reason, we will assess the Brief Pain Inventory (BPI), it is used to evaluate the subject's perception of pain severity and its interference. Moreover, we will assess neuropathic pain symptoms with the NPSI to detect paresthesia/dysaesthesia, evoked pain and paroxysmal pain. The catastrophizing score will be measured with the Pain Catastrophizing Helplessness Subscale. Also,we will assess the disability after whiplash using the Neck Disability Index.

Conditioned Pain Modulation over the tenar eminence. The test will be a heat tonic stimulus which evoke a 3-pain intensity. The conditioning stimulus will be a cold water immersion (12ºC)

Sponsors

Hospital Nacional de Parapléjicos de Toledo
CollaboratorOTHER
University of Castilla-La Mancha
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Whiplash syndrome * Chronic pain * Age between 18 to 65 years * 4 months to 2 years after the whiplash syndrome

Exclusion criteria

* Neurological disease * Claustrophobia

Design outcomes

Primary

MeasureTime frameDescription
Metabolite concentrationsBaseline at 0 minThe metabolite concentrations will be measured by magnetic resonance (spectroscopy)
Conditioned Pain ModulationBaseline at 0 minConditioned Pain Modulation will be measured by a Pathway system (Medoc Ltd)
Brief Pain InventoryBaseline at 0 minBrief Pain Inventory (BPI), it is used to evaluate the subject's perception of pain severity and its interference.
Neurophatic Pain Symptoms InventoryBaseline at 0 minNeurophatic Pain Symptoms Inventory (NPSI), it is used to detect paresthesia/dysaesthesia, evoked pain and paroxysmal pain.
Pain Catastrophizing Helplessness SubscaleBaseline at 0 minPain Catastrophizing Helplessness Subscale it is used to assess the catastrophizing score
Neck Disability IndexBaseline at 0 minNeck Disability Index (NDI), it is used to assess the disability after whiplash syndrome

Contacts

Primary ContactDiego Serrano-Muñoz, MsC
dserranomu@externas.sescam.jccm.es+34 925 24 77 00
Backup ContactJulian Taylor-Green, PhD
jscott@sescam.org+34 925 24 77 00

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026